S. J. Harland

1.6k total citations
32 papers, 1.1k citations indexed

About

S. J. Harland is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, S. J. Harland has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in S. J. Harland's work include Testicular diseases and treatments (8 papers), Cancer Treatment and Pharmacology (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). S. J. Harland is often cited by papers focused on Testicular diseases and treatments (8 papers), Cancer Treatment and Pharmacology (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). S. J. Harland collaborates with scholars based in United Kingdom, United States and Australia. S. J. Harland's co-authors include K. D. Bagshawe, P. W. Nicholson, A H Calvert, Bridget A. Robinson, B D Evans, E. Wiltshaw, Graham M. Mead, Pat Cook, M C Parkinson and J.T. Roberts and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

S. J. Harland

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. J. Harland United Kingdom 18 410 398 390 219 172 32 1.1k
Benno Mann Germany 18 323 0.8× 388 1.0× 318 0.8× 147 0.7× 92 0.5× 34 1.1k
F Sellner Austria 13 559 1.4× 283 0.7× 470 1.2× 485 2.2× 114 0.7× 34 1.1k
John L. Hays United States 23 244 0.6× 658 1.7× 765 2.0× 263 1.2× 314 1.8× 98 1.6k
Şennur İlvan Türkiye 19 206 0.5× 131 0.3× 212 0.5× 153 0.7× 298 1.7× 78 1.1k
I Fryatt United Kingdom 14 261 0.6× 136 0.3× 442 1.1× 316 1.4× 462 2.7× 20 1.1k
David Ransom Australia 18 173 0.4× 583 1.5× 524 1.3× 185 0.8× 57 0.3× 36 1.3k
Paul Thompson New Zealand 20 267 0.7× 376 0.9× 311 0.8× 165 0.8× 69 0.4× 44 1.1k
Eijiro Nakamura Japan 19 233 0.6× 512 1.3× 574 1.5× 472 2.2× 51 0.3× 59 1.4k
M Yakushiji Japan 23 424 1.0× 470 1.2× 417 1.1× 157 0.7× 772 4.5× 161 1.7k
W W ten Bokkel Huinink Netherlands 11 604 1.5× 182 0.5× 408 1.0× 163 0.7× 558 3.2× 20 1.2k

Countries citing papers authored by S. J. Harland

Since Specialization
Citations

This map shows the geographic impact of S. J. Harland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. J. Harland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. J. Harland more than expected).

Fields of papers citing papers by S. J. Harland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. J. Harland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. J. Harland. The network helps show where S. J. Harland may publish in the future.

Co-authorship network of co-authors of S. J. Harland

This figure shows the co-authorship network connecting the top 25 collaborators of S. J. Harland. A scholar is included among the top collaborators of S. J. Harland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. J. Harland. S. J. Harland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hilson, A. J.W., Cornelius Lewis, & S. J. Harland. (2015). The Permeability of the Human Bladder to Water Assessed Using Tritiated Water. Contributions to nephrology. 79. 41–44. 10 indexed citations
2.
Harland, S. J., et al.. (2007). Do all patients with bilateral testis cancer have a hereditary predisposition?. International Journal of Andrology. 30(4). 251–255. 4 indexed citations
3.
Harland, S. J.. (2005). A randomised trial of radical radiotherapy in pT1G3 NXM0 bladder cancer (MRC BS06). Journal of Clinical Oncology. 23(16_suppl). 4505–4505. 1 indexed citations
4.
Brown, Richard S., Joanne Edwards, Ahmet Doǧan, et al.. (2002). Amplification of the androgen receptor gene in bone metastases from hormone‐refractory prostate cancer. The Journal of Pathology. 198(2). 237–244. 70 indexed citations
5.
Brown, Richard S., Ahmet Doǧan, Peter J. Ell, et al.. (2002). The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer. Prostate Cancer and Prostatic Diseases. 5(2). 144–151. 10 indexed citations
6.
Fosså, S.D., Stuart Kaye, S. J. Harland, et al.. (1998). Adjuvant bleomycin, vincristine and cisplatin (BOP) for high risk clinical stage I (HRCS 1) non-seminomatous germ cell tumours (NSGCT) - a Medical Research Council (MRC) pilot study.. UCL Discovery (University College London). 12 indexed citations
8.
Nicholson, P. W. & S. J. Harland. (1995). Inheritance and testicular cancer. British Journal of Cancer. 71(2). 421–426. 67 indexed citations
9.
Hansen, Lars Hestbjerg, et al.. (1994). Metabolism of ifosfamide during a 3 day infusion. British Journal of Cancer. 69(5). 931–936. 14 indexed citations
10.
Harland, S. J., et al.. (1993). Misdiagnosis of Prostatic Primary Duct Carcinoma. British Journal of Urology. 72(6). 978–979. 1 indexed citations
11.
Harland, S. J., Pat Cook, S. D. Fosså, et al.. (1993). Risk Factors for Carcinoma in situof the Contralateral Testis inPatients with Testicular Cancer. European Urology. 23(1). 115–119. 21 indexed citations
12.
Fosså, Sophie D., S. J. Harland, Stan B. Kaye, et al.. (1992). Initial Combination Chemotherapy with Cisplatin, Methotrexate and Vinblastine in Locally Advanced Transitional Cell Carcinoma—Response Rate and Pitfalls. British Journal of Urology. 70(2). 161–168. 18 indexed citations
13.
Jones, Terence R., AH Calvert, A.L. Jackman, et al.. (1986). ChemInform Abstract: Quinazoline Antifolates Inhibiting Thymidylate Synthase: Variation of the N10 Substituent.. Chemischer Informationsdienst. 17(6). 3 indexed citations
14.
Smith, Ian E., B D Evans, S. J. Harland, et al.. (1985). High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma. Cancer Chemotherapy and Pharmacology. 14(2). 120–124. 64 indexed citations
15.
Timbrell, John A., B.K. Park, & S. J. Harland. (1985). A Study of the Effects of Rifampicin on Isoniazid Metabolism in Human Volunteer Subjects. Human Toxicology. 4(3). 279–285. 13 indexed citations
16.
Waxman, Jonathan, S. J. Harland, R. Charles Coombes, et al.. (1985). The treatment of postmenopausal women with advanced breast cancer with buserelin. Cancer Chemotherapy and Pharmacology. 15(2). 171–3. 40 indexed citations
17.
Timbrell, John A., et al.. (1984). Hydralazine-induced lupus: is there a toxic metabolic pathway?. European Journal of Clinical Pharmacology. 27(5). 555–559. 19 indexed citations
18.
Harland, S. J., Vincenzo Facchini, & John A. Timbrell. (1980). Hydrallazine-induced lupus erythematosus-like syndrome in a patient of the rapid acetylator phenotype.. BMJ. 281(6235). 273.2–274. 17 indexed citations
19.
Bagshawe, K. D. & S. J. Harland. (1976). Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system. Cancer. 38(1). 112–118. 83 indexed citations
20.
Bagshawe, K D & S. J. Harland. (1976). Tumours of the Cental Nervous System. Proceedings of the Royal Society of Medicine. 69(1). 51–53. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026